Medifast (MED) Stock Price, News & Analysis

Company Overview

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Key Stats

• Today's Range: $17.89 to $18.75
• 50-Day Range: $17.31 to $19.98
• 52-Week Range: $17.07 to $76.42
• Volume: 162,505 shs
• Average Volume: 392,483 shs
• Market Capitalization: $201.13 million
• P/E Ratio: 6.86
• Dividend Yield: N/A
• Price Target: $17.50
• Consensus Rating: Sell

Medifast Stock Analysis - MarketRank™

Medifast scored higher than 33% of companies evaluated by MarketBeat, and ranked 119th out of 143 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

Medifast has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Medifast has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: -16.07%

Earnings Growth

Earnings for Medifast are expected to decrease by -16.07% in the coming year, from $1.12 to $0.94 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medifast is 6.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.44.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medifast is 6.86, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 21.90.

Price to Book Value per Share Ratio

Medifast has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.68% of the float of Medifast has been sold short.

Short Interest Ratio / Days to Cover

Medifast has a short interest ratio ("days to cover") of 7.4.

Change versus previous month

Short interest in Medifast has recently decreased by 3.80%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Medifast does not currently pay a dividend.

Dividend Growth

Medifast does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Medifast is 246.27%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, Medifast will have a dividend payout ratio of 702.13% in the coming year. This indicates that Medifast may not be able to sustain their current dividend.

Sustainability and ESG

• Score: 2.0 / 5
• Environmental Score: -4.00

Percentage of Shares Shorted

16.68% of the float of Medifast has been sold short.

Short Interest Ratio / Days to Cover

Medifast has a short interest ratio ("days to cover") of 7.4.

Change versus previous month

Short interest in Medifast has recently decreased by 3.80%, indicating that investor sentiment is improving.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for Medifast this week, compared to 4 articles on an average week.

Search Interest

Only 5 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

5 people have added Medifast to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medifast insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.50% of the stock of Medifast is held by insiders.

Percentage Held by Institutions

95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MED Stock Analysis - Frequently Asked Questions

How have MED shares performed this year?

Medifast's stock was trading at $67.22 at the start of the year. Since then, MED shares have decreased by 72.7% and is now trading at $18.38.
View the best growth stocks for 2024 here.

How were Medifast's earnings last quarter?

Medifast, Inc. (NYSE:MED) released its quarterly earnings results on Monday, August, 5th. The specialty retailer reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.56. The specialty retailer had revenue of $168.56 million for the quarter, compared to analyst estimates of $160.44 million. Medifast had a net margin of 3.81% and a trailing twelve-month return on equity of 25.77%.

Who are Medifast's major shareholders?

Top institutional shareholders of Medifast include Values First Advisors Inc. (0.59%), Inspire Investing LLC (0.45%), Robeco Institutional Asset Management B.V. (0.19%) and SG Americas Securities LLC (0.10%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist.
View institutional ownership trends.

How do I buy shares of Medifast?

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

• Last Earnings: 8/05/2024
• Today: 10/31/2024
• Next Earnings (Confirmed): 11/04/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Miscellaneous food preparations & kindred products
• Sub-Industry: Personal Products
• Current Symbol: NYSE:MED
• CUSIP: 58470H10
• CIK: 910329
• Web: www.medifast1.com
• Phone: (410) 581-8042
• Fax: 410-581-8070
• Employees: 870
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $17.50
• High Stock Price Target: $17.50
• Low Stock Price Target: $17.50
• Potential Upside/Downside: -5.4%
• Consensus Rating: Sell
• Rating Score (0-4): 1.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $2.68
• Trailing P/E Ratio: 6.90
• Forward P/E Ratio: 16.51
• P/E Growth: N/A
• Net Income: $99.42 million
• Net Margins: 3.81%
• Pretax Margin: 4.84%
• Return on Equity: 25.77%
• Return on Assets: 17.04%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.98
• Quick Ratio: 2.46

Sales & Book Value

• Annual Sales: $1.07 billion
• Price / Sales: 0.19
• Cash Flow: $11.48 per share
• Price / Cash Flow: 1.61
• Book Value: $18.50 per share
• Price / Book: 1.00

Miscellaneous

• Outstanding Shares: 10,940,000
• Free Float: 10,664,000
• Market Cap: $202.28 million
• Optionable: Optionable
• Beta: 1.13